K130937 is an FDA 510(k) clearance for the WAVE 2G, SOUL. Classified as Masker, Tinnitus (product code KLW), Class II - Special Controls.
Submitted by Hansaton Akustik GmbH (Hamburg, DE). The FDA issued a Cleared decision on January 3, 2014 after a review of 274 days - an extended review cycle.
This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.3400 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ear, Nose, Throat review framework, consistent with the majority of Class II 510(k) submissions.
View all Hansaton Akustik GmbH devices